Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells

Shoukang Zhu, Xialin Liu, Ying Li, Pascal Goldschmidt-Clermont, Chunming Dong

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

OBJECTIVE - We have demonstrated that bone marrow cells from young and wild-type (WT), but not old apoE, mice are capable of preventing atherosclerosis. This study was performed to elucidate the numerical and functional changes underlying the efficacy difference between young and old bone marrow. METHODS AND RESULTS - CD34/VEGFR2 conventional endothelial progenitor cells and lin/cKit/Sca-1 hematopoietic stem cells did not differ numerically or functionally between young and old apoE bone marrow. Fluorescence- activated cell sorter analysis, however, showed that a group of cells (simple little cells or SLCs), characteristically located in the lower left quadrant of forward scatter/side scatter flow cytometric plot, were markedly decreased in old WT and apoE marrow, but abundantly present in young WT and apoE bone marrow. The SLC fraction was mainly composed of lin/cKit/Sca-1 cells. In vitro differentiation assay demonstrated substantially more efficient endothelial differentiation of lin/cKit/Sca-1 SLCs than other bone marrow fractions at a single cell level and en masse. Furthermore, old lin/cKit/Sca-1 SLCs had a trend of decreased endothelial differentiation capability. CONCLUSIONS - Lin/cKit/Sca-1 SLCs may represent a previously unrecognized cell population, enriched for endothelial progenitors. The identification of these cells may help improve the efficacy of cell therapy.

Original languageEnglish
Pages (from-to)113-119
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume27
Issue number1
DOIs
StatePublished - Jan 1 2007

Fingerprint

Bone Marrow Cells
Atherosclerosis
Apolipoproteins E
Bone Marrow
Cell- and Tissue-Based Therapy
Hematopoietic Stem Cells
Endothelial Progenitor Cells
Fluorescence
Population

Keywords

  • Aging
  • Atherosclerosis
  • Bone marrow
  • Endothelial progenitor cells
  • Vascular repair

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells. / Zhu, Shoukang; Liu, Xialin; Li, Ying; Goldschmidt-Clermont, Pascal; Dong, Chunming.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 27, No. 1, 01.01.2007, p. 113-119.

Research output: Contribution to journalArticle

@article{ba5ac93dcc9f4e58999885b95f2d528c,
title = "Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells",
abstract = "OBJECTIVE - We have demonstrated that bone marrow cells from young and wild-type (WT), but not old apoE, mice are capable of preventing atherosclerosis. This study was performed to elucidate the numerical and functional changes underlying the efficacy difference between young and old bone marrow. METHODS AND RESULTS - CD34/VEGFR2 conventional endothelial progenitor cells and lin/cKit/Sca-1 hematopoietic stem cells did not differ numerically or functionally between young and old apoE bone marrow. Fluorescence- activated cell sorter analysis, however, showed that a group of cells (simple little cells or SLCs), characteristically located in the lower left quadrant of forward scatter/side scatter flow cytometric plot, were markedly decreased in old WT and apoE marrow, but abundantly present in young WT and apoE bone marrow. The SLC fraction was mainly composed of lin/cKit/Sca-1 cells. In vitro differentiation assay demonstrated substantially more efficient endothelial differentiation of lin/cKit/Sca-1 SLCs than other bone marrow fractions at a single cell level and en masse. Furthermore, old lin/cKit/Sca-1 SLCs had a trend of decreased endothelial differentiation capability. CONCLUSIONS - Lin/cKit/Sca-1 SLCs may represent a previously unrecognized cell population, enriched for endothelial progenitors. The identification of these cells may help improve the efficacy of cell therapy.",
keywords = "Aging, Atherosclerosis, Bone marrow, Endothelial progenitor cells, Vascular repair",
author = "Shoukang Zhu and Xialin Liu and Ying Li and Pascal Goldschmidt-Clermont and Chunming Dong",
year = "2007",
month = "1",
day = "1",
doi = "10.1161/01.ATV.0000252035.12881.d0",
language = "English",
volume = "27",
pages = "113--119",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells

AU - Zhu, Shoukang

AU - Liu, Xialin

AU - Li, Ying

AU - Goldschmidt-Clermont, Pascal

AU - Dong, Chunming

PY - 2007/1/1

Y1 - 2007/1/1

N2 - OBJECTIVE - We have demonstrated that bone marrow cells from young and wild-type (WT), but not old apoE, mice are capable of preventing atherosclerosis. This study was performed to elucidate the numerical and functional changes underlying the efficacy difference between young and old bone marrow. METHODS AND RESULTS - CD34/VEGFR2 conventional endothelial progenitor cells and lin/cKit/Sca-1 hematopoietic stem cells did not differ numerically or functionally between young and old apoE bone marrow. Fluorescence- activated cell sorter analysis, however, showed that a group of cells (simple little cells or SLCs), characteristically located in the lower left quadrant of forward scatter/side scatter flow cytometric plot, were markedly decreased in old WT and apoE marrow, but abundantly present in young WT and apoE bone marrow. The SLC fraction was mainly composed of lin/cKit/Sca-1 cells. In vitro differentiation assay demonstrated substantially more efficient endothelial differentiation of lin/cKit/Sca-1 SLCs than other bone marrow fractions at a single cell level and en masse. Furthermore, old lin/cKit/Sca-1 SLCs had a trend of decreased endothelial differentiation capability. CONCLUSIONS - Lin/cKit/Sca-1 SLCs may represent a previously unrecognized cell population, enriched for endothelial progenitors. The identification of these cells may help improve the efficacy of cell therapy.

AB - OBJECTIVE - We have demonstrated that bone marrow cells from young and wild-type (WT), but not old apoE, mice are capable of preventing atherosclerosis. This study was performed to elucidate the numerical and functional changes underlying the efficacy difference between young and old bone marrow. METHODS AND RESULTS - CD34/VEGFR2 conventional endothelial progenitor cells and lin/cKit/Sca-1 hematopoietic stem cells did not differ numerically or functionally between young and old apoE bone marrow. Fluorescence- activated cell sorter analysis, however, showed that a group of cells (simple little cells or SLCs), characteristically located in the lower left quadrant of forward scatter/side scatter flow cytometric plot, were markedly decreased in old WT and apoE marrow, but abundantly present in young WT and apoE bone marrow. The SLC fraction was mainly composed of lin/cKit/Sca-1 cells. In vitro differentiation assay demonstrated substantially more efficient endothelial differentiation of lin/cKit/Sca-1 SLCs than other bone marrow fractions at a single cell level and en masse. Furthermore, old lin/cKit/Sca-1 SLCs had a trend of decreased endothelial differentiation capability. CONCLUSIONS - Lin/cKit/Sca-1 SLCs may represent a previously unrecognized cell population, enriched for endothelial progenitors. The identification of these cells may help improve the efficacy of cell therapy.

KW - Aging

KW - Atherosclerosis

KW - Bone marrow

KW - Endothelial progenitor cells

KW - Vascular repair

UR - http://www.scopus.com/inward/record.url?scp=33847657912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847657912&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.0000252035.12881.d0

DO - 10.1161/01.ATV.0000252035.12881.d0

M3 - Article

C2 - 17095715

AN - SCOPUS:33847657912

VL - 27

SP - 113

EP - 119

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 1

ER -